UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

The Prostate, 1996-12, Vol.29 (6), p.371-380

1996

Volltextzugriff (PDF)

Safety and efficacy of dendritic cell (DC)-based cryoimmunotherapy (CryoIT) combined with checkpoint inhibition in a prospective non-randomized Phase I trial of metastatic castration resistant prostate cancer (mCRPC)

European urology open science (Online), 2020-07, Vol.19, p.e1844-e1845

2020

Volltextzugriff (PDF)

Follow-up evaluation of a phase II prostate cancer vaccine trial

The Prostate, 1999-07, Vol.40 (2), p.125-129

1999

Volltextzugriff (PDF)

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

The Prostate, 1999-01, Vol.38 (1), p.73-78

1999

Volltextzugriff (PDF)

Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment

The Prostate, 1999-04, Vol.39 (1), p.54-59

1999

Volltextzugriff (PDF)

Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides

The Prostate, 1998-06, Vol.36 (1), p.39-44

1998

Volltextzugriff (PDF)

Modern prostate brachytherapy

CA: a cancer journal for clinicians, 2000-11, Vol.50 (6), p.380-393

2000

Volltextzugriff (PDF)

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

The Prostate, 1997-09, Vol.32 (4), p.272-278

1997

Volltextzugriff (PDF)

SHOULD BRACHYTHERAPY BE CONSIDERED A THERAPEUTIC OPTION IN LOCALIZED PROSTATE CANCER?

Urologic clinics of North America, 1996-11, Vol.23 (4), p.633-650

1996

Volltextzugriff (PDF)

GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial

The Prostate, 1999-06, Vol.39 (4), p.291-297

1999

Volltextzugriff (PDF)

Dendritic cell-based immunotherapy of prostate cancer

Critical reviews in immunology, 1998, Vol.18 (1-2), p.109-119

1998

Volltextzugriff (PDF)

Radiotherapy for prostate cancer: Brachytherapy alone

Urology (Ridgewood, N.J.), 2004-10, Vol.64 (4), p.631-632

Ragde, Haakon

2004

Volltextzugriff (PDF)

Ten‐year disease free survival after transperineal sonography‐guided iodine‐125 brachytherapy with or without 45‐gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma

Cancer, 1998-09, Vol.83 (5), p.989-1001

1998

Volltextzugriff (PDF)

Brachytherapy for prostate cancer

CA: a cancer journal for clinicians, 1995-05, Vol.45 (3), p.165-178

1995

Volltextzugriff (PDF)

Prostate cancer brachytherapy

Seminars in surgical oncology, 1997-11, Vol.13 (6), p.389-390

Ragde, H

1997

Volltextzugriff (PDF)

Interstitial iodine‐125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma

Cancer, 1997-08, Vol.80 (3), p.442-453

1997

Volltextzugriff (PDF)

Comparison of prostate specific membrane antigen, and prostate specific antigen levels in prostatic cancer patients

Anticancer research, 1995-07, Vol.15 (4), p.1473

1995

Volltextzugriff (PDF)

An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow‐up

Cancer, 2002-11, Vol.95 (10), p.2126-2135

2002

Volltextzugriff (PDF)

Reduction of radioactive seed embolization to the lung following prostate brachytherapy

International journal of radiation oncology, biology, physics, 1998-12, Vol.42 (5), p.1063-1067

1998

Volltextzugriff (PDF)

DOES BRACHYTHERAPY HAVE A ROLE IN THE TREATMENT OF PROSTATE CANCER?

Hematology/oncology clinics of North America, 1996-06, Vol.10 (3), p.653-673

1996

Volltextzugriff (PDF)

Transperineal ultrasound-guided implantation of the prostate: morbidity and complications

Scandinavian journal of urology and nephrology. Supplement, 1991, Vol.137, p.113

1991

Volltextzugriff (PDF)

Ultrasound-guided prostate biopsy Biopty gun superior to aspiration

Urology (Ridgewood, N.J.), 1988-12, Vol.32 (6), p.503-506

1988

Volltextzugriff (PDF)

Workgroup 3: Current prognostic factors and their relevance to staging

Cancer, 1996-07, Vol.78 (2), p.369-371

1996

Volltextzugriff (PDF)

Measurement of prostate-specific membrane antigen in the serum with a new antibody

The Prostate, 1996-04, Vol.28 (4), p.266-271

1996

Volltextzugriff (PDF)

Brachytherapy and organ preservation in the management of carcinoma of the prostate

Seminars in radiation oncology, 1993-10, Vol.3 (4), p.240-249

1993

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(73)

Sprache

Englisch
(73)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

Safety and efficacy of dendritic cell (DC)-based cryoimmunotherapy (CryoIT) combined with checkpoint inhibition in a prospective non-randomized Phase I trial of metastatic castration resistant prostate cancer (mCRPC)

Follow-up evaluation of a phase II prostate cancer vaccine trial

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment

Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides

Modern prostate brachytherapy

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

SHOULD BRACHYTHERAPY BE CONSIDERED A THERAPEUTIC OPTION IN LOCALIZED PROSTATE CANCER?

GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial

Dendritic cell-based immunotherapy of prostate cancer

Radiotherapy for prostate cancer: Brachytherapy alone

Ten‐year disease free survival after transperineal sonography‐guided iodine‐125 brachytherapy with or without 45‐gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma

Brachytherapy for prostate cancer

Prostate cancer brachytherapy

Interstitial iodine‐125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma

Comparison of prostate specific membrane antigen, and prostate specific antigen levels in prostatic cancer patients

An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow‐up

Reduction of radioactive seed embolization to the lung following prostate brachytherapy

DOES BRACHYTHERAPY HAVE A ROLE IN THE TREATMENT OF PROSTATE CANCER?

Transperineal ultrasound-guided implantation of the prostate: morbidity and complications

Ultrasound-guided prostate biopsy Biopty gun superior to aspiration

Workgroup 3: Current prognostic factors and their relevance to staging

Measurement of prostate-specific membrane antigen in the serum with a new antibody

Brachytherapy and organ preservation in the management of carcinoma of the prostate

Suchergebnisse filtern